Kunkel Lori Anne

Enliven Therapeutics, Inc. · Director

Kunkel Lori Anne is listed in public filings as director. This Kunkel Lori Anne insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Enliven Therapeutics, Inc. (ELVN), ORIC Pharmaceuticals, Inc. (ORIC), and Nurix Therapeutics, Inc. (NRIX). Investors use Kunkel Lori Anne's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Enliven Therapeutics, Inc.ELVN$465k17.1k sharesGrant / ExerciseFeb 12, 2026$465.1K17.1k shares$27.16--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
ORIC Pharmaceuticals, Inc.ORIC$327k40k sharesGrant / ExerciseJan 2, 2026$326.8K40k shares$8.17--
Enliven Therapeutics, Inc.ELVN$4.2k3.7k sharesGrant / ExerciseDec 17, 2025$17.9K16k shares$1.12--
ORIC Pharmaceuticals, Inc.ORIC$123k15.6k sharesGrant / ExerciseDec 8, 2025$79.0K10k shares$7.90--
ORIC Pharmaceuticals, Inc.ORIC$05.5k sharesGrant / ExerciseDec 4, 2025$20.8K5.5k shares$3.75--
Nurix Therapeutics, Inc.NRIX$238k25k sharesGrant / ExerciseMay 19, 2025$237.8K25k shares$9.51--
ORIC Pharmaceuticals, Inc.ORIC$020.5k sharesGrant / ExerciseMar 3, 2025$129.8K20.5k shares$6.33--
ORIC Pharmaceuticals, Inc.ORIC$21k5.5k sharesGrant / ExerciseMar 3, 2025$103.7K27.7k shares$3.75--
Enliven Therapeutics, Inc.ELVN$345k15.4k sharesGrant / ExerciseFeb 6, 2025$345.3K15.4k shares$22.47--
ORIC Pharmaceuticals, Inc.ORIC$289k35k sharesGrant / ExerciseJan 2, 2025$289.1K35k shares$8.26--
ORIC Pharmaceuticals, Inc.ORIC$202k25.6k sharesGrant / ExerciseJun 12, 2024$202.2K25.6k shares$7.90--